126 related articles for article (PubMed ID: 1797584)
1. Monensin-resistant LLC-PK1 cell mutants are affected in recycling of the adenylate cyclase-stimulating vasopressin V2-receptor.
Jans DA; Jans P; Luzius H; Fahrenholz F
Mol Cell Endocrinol; 1991 Oct; 81(1-3):165-74. PubMed ID: 1797584
[TBL] [Abstract][Full Text] [Related]
2. N-glycosylation plays a role in biosynthesis and internalization of the adenylate cyclase stimulating vasopressin V2-receptor of LLC-PK1 renal epithelial cells: an effect of concanavalin A on binding and expression.
Jans DA; Jans P; Luzius H; Fahrenholz F
Arch Biochem Biophys; 1992 Apr; 294(1):64-9. PubMed ID: 1532296
[TBL] [Abstract][Full Text] [Related]
3. Lateral mobility of the phospholipase C-activating vasopressin V1-type receptor in A7r5 smooth muscle cells: a comparison with the adenylate cyclase-coupled V2-receptor.
Jans DA; Peters R; Fahrenholz F
EMBO J; 1990 Sep; 9(9):2693-9. PubMed ID: 2143982
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin V2-receptor mobile fraction and ligand-dependent adenylate cyclase activity are directly correlated in LLC-PK1 renal epithelial cells.
Jans DA; Peters R; Jans P; Fahrenholz F
J Cell Biol; 1991 Jul; 114(1):53-60. PubMed ID: 1646825
[TBL] [Abstract][Full Text] [Related]
5. The adenylate cyclase-coupled vasopressin V2-receptor is highly laterally mobile in membranes of LLC-PK1 renal epithelial cells at physiological temperature.
Jans DA; Peters R; Zsigo J; Fahrenholz F
EMBO J; 1989 Sep; 8(9):2481-8. PubMed ID: 2531084
[TBL] [Abstract][Full Text] [Related]
6. A novel LLC-PK1 renal epithelial cell mutant impaired in in vivo down-regulation of cAMP-mediated hormonal response.
Jans DA; Resink TJ; Hemmings BA
Arch Biochem Biophys; 1991 Mar; 285(2):377-81. PubMed ID: 1716864
[TBL] [Abstract][Full Text] [Related]
7. Complementation between LLC-PK1 mutants affected in polypeptide hormone-receptor function.
Jans DA; Resink TJ; Hemmings BA
Eur J Biochem; 1987 Feb; 162(3):571-6. PubMed ID: 3030741
[TBL] [Abstract][Full Text] [Related]
8. Desensitization of LLC-PK1 cells by vasopressin results in receptor down-regulation.
Lester BR; Sheppard JR; Burman M; Somkuti SB; Stassen FL
Mol Cell Endocrinol; 1985 May; 40(2-3):193-204. PubMed ID: 2989032
[TBL] [Abstract][Full Text] [Related]
9. cAMP-dependent protein kinase activation affects vasopressin V2-receptor number and internalization in LLC-PK1 renal epithelial cells.
Jans DA; Hemmings BA
FEBS Lett; 1991 Apr; 281(1-2):267-71. PubMed ID: 1707831
[TBL] [Abstract][Full Text] [Related]
10. Ammonium chloride affects receptor number and lateral mobility of the vasopressin V2-type receptor in the plasma membrane of LLC-PK1 renal epithelial cells: role of the cytoskeleton.
Jans DA; Peters R; Jans P; Fahrenholz F
Exp Cell Res; 1990 Nov; 191(1):121-8. PubMed ID: 2146138
[TBL] [Abstract][Full Text] [Related]
11. An inverse relationship between receptor internalization and the fraction of laterally mobile receptors for the vasopressin renal-type V2-receptor. An active role for receptor immobilization in down-regulation?
Jans DA; Peters R; Fahrenholz F
FEBS Lett; 1990 Nov; 274(1-2):223-6. PubMed ID: 2147660
[TBL] [Abstract][Full Text] [Related]
12. Isolation and genetic characterization of a renal epithelial cell mutant defective in vasopressin (V2) receptor binding and function.
Luzius H; Jans DA; Jans P; Fahrenholz F
Exp Cell Res; 1991 Aug; 195(2):478-84. PubMed ID: 1649058
[TBL] [Abstract][Full Text] [Related]
13. Properties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site.
Schülein R; Liebenhoff U; Müller H; Birnbaumer M; Rosenthal W
Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):611-6. PubMed ID: 8573100
[TBL] [Abstract][Full Text] [Related]
14. Internalization of vasopressin analogs in kidney and smooth muscle cells: evidence for receptor-mediated endocytosis in cells with V2 or V1 receptors.
Lutz W; Sanders M; Salisbury J; Kumar R
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6507-11. PubMed ID: 2144348
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles.
Maggi M; Kassis S; Malozowski S; Guardabasso V; Rodbard D
Proc Natl Acad Sci U S A; 1986 Dec; 83(23):8824-8. PubMed ID: 2947237
[TBL] [Abstract][Full Text] [Related]
16. Lateral mobility of the antagonist-occupied V2 vasopressin receptor in membranes of renal epithelial cells.
Pavo I; Jans DA; Peters R; Penke B; Fahrenholz F
Biochim Biophys Acta; 1994 Sep; 1223(2):240-6. PubMed ID: 8086494
[TBL] [Abstract][Full Text] [Related]
17. Internalization of V2-vasopressin receptors in LLC-PK1-cells: evidence for receptor-mediated endocytosis.
Hocher B; Merker HJ; Dürr JA; Schiller S; Gross P; Hensen J
Biochem Biophys Res Commun; 1992 Aug; 186(3):1376-83. PubMed ID: 1387309
[TBL] [Abstract][Full Text] [Related]
18. Biotinyl analogues of vasopressin as biologically active probes for vasopressin receptor expression in cultured cells.
Jans DA; Bergmann L; Peters R; Fahrenholz F
J Biol Chem; 1990 Aug; 265(24):14599-605. PubMed ID: 2143764
[TBL] [Abstract][Full Text] [Related]
19. Renal immunocytochemical distribution and pharmacological properties of the dual angiotensin II/AVP receptor.
Gonzalez CB; Herrera VL; Ruiz-Opazo N
Hypertension; 1997 Apr; 29(4):957-61. PubMed ID: 9095083
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin receptors in human seminal vesicles: identification, pharmacologic characterization, and comparison with the vasopressin receptors present in the human kidney.
Maggi M; Baldi E; Genazzani AD; Giannini S; Natali A; Costantini A; Rodbard D; Serio M
J Androl; 1989; 10(5):393-400. PubMed ID: 2592268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
